What are the recommended dosing regimens and frequencies for Macrobid (nitrofurantoin) in adults with uncomplicated urinary tract infection, for prophylaxis, and in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Macrobid Dosing and Frequency

For adults with uncomplicated UTI, prescribe Macrobid (nitrofurantoin monohydrate/macrocrystals) 100 mg twice daily for 5 days, taken with food. 1, 2

Adult Dosing for Uncomplicated Cystitis

The most current European guidelines recommend nitrofurantoin as first-line therapy for acute cystitis in women 1. The specific regimens are:

  • Nitrofurantoin monohydrate/macrocrystals (Macrobid): 100 mg twice daily for 5 days 1
  • Nitrofurantoin macrocrystal: 50-100 mg four times daily for 5 days 1
  • Nitrofurantoin macrocrystal prolonged release: 100 mg twice daily for 5 days 1

The FDA label states 100 mg every 12 hours for 7 days 2, but the most recent 2026 European guidelines support the shorter 5-day course 1, which is consistent with high-quality trial data showing 5-day nitrofurantoin is more effective than single-dose fosfomycin 3.

Key Administration Details

  • Always take with food - this increases bioavailability by approximately 40% 2
  • The twice-daily Macrobid formulation is preferred over four-times-daily dosing for better adherence

Treatment in Men

For men with uncomplicated UTI (no prostate involvement), nitrofurantoin can be used, though duration recommendations are less established 1. The FDA label suggests 7 days 2, and this longer duration is reasonable given limited evidence in males.

Prophylaxis Dosing

For recurrent UTI prophylaxis in adults, use 50 mg once daily at bedtime rather than 100 mg daily 4.

A 2022 cohort study of 1,893 patients demonstrated that 50 mg daily prophylaxis had:

  • Equivalent effectiveness to 100 mg in preventing UTI recurrence (14.8% vs 14.9% infection rates) 4
  • Significantly fewer adverse effects, with lower rates of cough (HR 1.82), dyspnea (HR 2.68), and nausea (HR 2.43) compared to 100 mg 4

The 2026 European guidelines do not specify prophylaxis dosing but acknowledge nitrofurantoin as an appropriate prophylactic agent 1.

Pediatric Dosing

For children over 12 years: 100 mg every 12 hours for 5-7 days 2, 5

The 2026 pediatric UTI guidelines recommend:

  • Ages 2-5 years with nonfebrile UTI (cystitis): 3-5 days of antibiotics 5
  • Ages 2 months to 24 months with febrile UTI: 5-7 days 5
  • Ages >2 years with febrile UTI/pyelonephritis: 5-7 days 5
  • High-risk children (ages 8 days-2 months, anatomic abnormalities, bacteremia, poor response): 7-14 days 5

While nitrofurantoin is mentioned as an option in pediatric studies 6, the FDA label only provides dosing for children over 12 years 2. For younger children, nitrofurantoin dosing should be calculated based on weight (typically 5-7 mg/kg/day divided into 4 doses for macrocrystalline formulations).

Important Pediatric Considerations

  • Nitrofurantoin prophylaxis in children with neurogenic bladder showed effectiveness at once-daily dosing 6
  • The drug is generally not recommended for infants under 1 month due to risk of hemolytic anemia

Critical Caveats

Do not use nitrofurantoin for suspected pyelonephritis - it achieves low serum and tissue concentrations and is only effective for bladder infections 2, 1.

Contraindications include:

  • Creatinine clearance <30 mL/min (inadequate urinary concentrations)
  • Pregnancy at term (risk of hemolytic anemia in newborn)
  • Infants under 1 month of age

Common pitfall: The brown discoloration of urine is expected and harmless 2. Warn patients to avoid unnecessary concern or discontinuation.

Resistance considerations: Nitrofurantoin maintains excellent activity against E. coli and other common uropathogens with minimal resistance development, making it ideal for first-line use 2, 7. It has no activity against Proteus, Serratia, or Pseudomonas species 2.

Related Questions

What is the recommended dosing regimen of nitrofurantoin (Macrobid) for an adult with an uncomplicated urinary tract infection and for prophylaxis?
What is the recommended nitrofurantoin (Macrobid) dosing for uncomplicated urinary tract infection in adults and children, and what alternatives should be used if renal function is impaired or the patient is allergic?
What is the recommended nitrofurantoin dosing for uncomplicated urinary tract infection in adults, including adjustments for renal function, pregnancy, and in children?
What is the appropriate dosing of nitrofurantoin (Macrobid) for a 13-year-old with an acute urinary tract infection?
Is Macrodantin (nitrofurantoin) effective when dosed twice daily for uncomplicated urinary tract infection?
Can a patient allergic to lamotrigine safely take guaifenesin?
How should I respond to a parent who says a vaccinated 10‑year‑old cannot have chickenpox and is concerned about a 1‑month‑old infant’s risk, explaining breakthrough varicella, the benefits of vaccination, and recommended prophylaxis for the infant?
Can a patient with lymphomatoid papulosis be treated with methotrexate?
In a stable patient discharged after treatment for methicillin-resistant Staphylococcus epidermidis (MRSE) bacteremia who is receiving levetiracetam for seizure control, is linezolid (Zyvox) contraindicated with levetiracetam (Keppra)?
Which baseline blood tests are required before initiating methotrexate therapy?
What is the safest sleep aid for an adult with cirrhosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.